Ablatus Therapeutics Limited
Private Limited Company · Leeds
Creditors Voluntary Liquidation (CVL)United KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2022-12-31
IXBRL · 125 source facts · 26 selected values
Not assessedlegacy record
Accounts to 2022-12-31
IXBRL · 125 source facts · 26 selected values
Not assessed
legacy record
- Reporting period
- 2022-01-01 to 2022-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 60
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0016_09812865_20221231
- Source archive
- Accounts_Monthly_Data-June2023.zip
Accounts to 2021-12-31
IXBRL · 120 source facts · 26 selected values
Not assessedlegacy record
Accounts to 2021-12-31
IXBRL · 120 source facts · 26 selected values
Not assessed
legacy record
- Reporting period
- 2021-01-01 to 2021-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 55
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0109_09812865_20211231
- Source archive
- Accounts_Monthly_Data-August2022.zip
Accounts to 2020-12-31
IXBRL · 123 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 123 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 59
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0094_09812865_20201231
- Source archive
- Accounts_Monthly_Data-September2021.zip
Accounts to 2018-12-31
IXBRL · 131 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2018-12-31
IXBRL · 131 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2018-01-01 to 2018-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 85
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0066_09812865_20181231
- Source archive
- Accounts_Monthly_Data-May2019.zip
Registered details
09812865- Status
- Liquidation
- Type
- Private Limited Company
- Incorporated
- 2015-10-07
- Jurisdiction
- —
- Registered office
- MORWICK HALL 1.8, MORTEC PARK, LEEDS, WEST YORKSHIRE, LS15 4TA
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
2 matched grantsBimodal Electric Tissue Ablation: First-in-Person Clinical StudyLeadInnovate UK · Study · 2020-08-01 – 2022-07-31 · with 2 other participants£672,972awarded
Bimodal Electric Tissue Ablation: First-in-Person Clinical StudyLead
Innovate UK · Study · 2020-08-01 – 2022-07-31 · with 2 other participants
£672,972
awarded
Ablatus Therapeutics Limitedlead£672,972
Cambridge University Hospitals NHS Foundation Trust£180,794
Bimodal Electric Tissue Ablation - Next Generation Radiofrequency AblationLeadInnovate UK · Collaborative R&D · 2017-09-01 – 2019-05-31 · with 1 other participant£268,818awarded
Bimodal Electric Tissue Ablation - Next Generation Radiofrequency AblationLead
Innovate UK · Collaborative R&D · 2017-09-01 – 2019-05-31 · with 1 other participant
£268,818
awarded
Ablatus Therapeutics Limitedlead£268,818